Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of the RET proto-oncogene in sporadic parathyroid adenomas.

The Journal of pathology - 1 Oct 1996

Williams G H, Rooney S, Carss A, Cummins G, Thomas G A, Williams E D

Abstract excerpt

Missense germline mutations of the RET proto-oncogene have recently been identified in the hereditary cancer syndromes MEN2A, MEN2B, and FMTC, all characterized by medullary carcinoma, but also including phaeochromocytoma in MEN2A and MEN2B and parathyroid disease in MEN2A. In addition, somatic RET proto-oncogene mutations have been identified in a subset of sporadic medullary carcinomas and phaeochromocytomas....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Receptor Protein-Tyrosine Kinases
Share to Adenoma
Share to Drosophila Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Polymerase Chain Reaction

Share to Proto-Oncogene Mas

Share to Proto-Oncogene Proteins

Share to Transcription, Genetic

Source

Identifiers

PMID: 8976870
DOI: 10.1002/(SICI)1096-9896(199610)180:2<138::AID-PATH652>3.0.CO;2-H

Genes

RET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of the RET proto-oncogene in sporadic parathyroid adenomas.PMID 8976870Read ↗

Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2.Semantic proximity Read ↗

RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.Semantic proximity Read ↗

RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine TumorsSemantic proximity Read ↗

Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma.Semantic proximity Read ↗

Germline and somatic mutations of the RET proto-oncogene in apparently sporadic medullary thyroid carcinomas.Semantic proximity Read ↗

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.Semantic proximity Read ↗

Tumor-specific mutations in the tyrosine kinase domain of the RET proto-oncogene in pheochromocytomas of sporadic type.Semantic proximity Read ↗

Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.Semantic proximity Read ↗

RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.Semantic proximity Read ↗

RET proto-oncogene in the development of human cancer.Semantic proximity Read ↗

RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer.Semantic proximity Read ↗

A Mutation in the RET Protooncogene Associated with Multiple Endocrine Neoplasia Type 2B and Sporadic Medullary Thyroid CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.